Breakthrough

Bergamot Citrus Extract: Italy's Answer to High Cholesterol

Updated Apr 26, 2026 · 7 min read

Bergamot (Citrus bergamia) is a hybrid citrus fruit grown almost only in the Calabria region of southern Italy. Its peel is rich in unusual flavonoids — especially brutieridin and melitidin — that act like very mild plant statins by partially blocking HMG-CoA reductase, the enzyme that makes cholesterol. Italian researchers have built a steady evidence base for standardized bergamot extract (often labeled BPF, for Bergamot Polyphenolic Fraction) over the last 15 years.

What the lipid trials show

The most useful summary is a 2019 systematic review by Lamiquiz-Moneo and colleagues in Critical Reviews in Food Science and Nutrition (PMID 31670973). It pooled 12 human studies. Across those trials, total cholesterol fell by 12–31%, LDL by 8–41%, and triglycerides by 12–40%. Most studies also showed a small rise in HDL. Doses ranged from about 500 to 1,500 mg/day of standardized bergamot extract, usually for 30–180 days. The reviewers note the trials were heterogeneous and quality was modest, so the headline numbers should be read as a plausible range, not a fixed effect size.

Mechanism: more than just statin-like activity

Brutieridin and melitidin compete with HMG-CoA reductase, but per molecule they are far weaker than prescription statins. Bergamot likely works through several pathways at once: light HMG-CoA reductase blockade, AMPK activation (helpful for glucose and fat metabolism), increased PON1 activity (which protects HDL from oxidation), and reduced new fat-making in the liver. The combined effect is meaningful even though no single mechanism is strong on its own.

Statin add-on or alternative

The clearest add-on data come from Gliozzi and colleagues in International Journal of Cardiology, 2013 (PMID 24239156). Seventy-seven adults with mixed high cholesterol were randomized to placebo, rosuvastatin 10 mg, rosuvastatin 20 mg, BPF 1,000 mg, or BPF 1,000 mg + rosuvastatin 10 mg for 30 days. Adding BPF to the low-dose statin produced larger drops in LDL and oxidized-LDL markers than rosuvastatin alone. That makes bergamot a reasonable option for people who get muscle pain on higher statin doses and want to stay on the lowest effective dose. As a stand-alone, it is reasonable for adults with mild-to-moderate high cholesterol who do not yet need a prescription. It should not replace a statin in someone with established heart disease.

Standardization and safety

Look for products standardized to about 40% polyphenols or to a defined BPF fraction. Generic “bergamot extract” with no standardization can be inconsistent. Bergamot is well tolerated; mild stomach upset is the most common report. Because it lowers lipids, recheck a lipid panel at 8–12 weeks, and tell any prescriber who is also adjusting cholesterol medications.

Sources

  1. Lamiquiz-Moneo I, et al. “Effect of bergamot on lipid profile in humans: a systematic review.” Critical Reviews in Food Science and Nutrition, 2020. PMID 31670973; DOI 10.1080/10408398.2019.1677554.
  2. Gliozzi M, et al. “Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia.” International Journal of Cardiology, 2013. PMID 24239156; DOI 10.1016/j.ijcard.2013.08.125.
  3. Mollace V, et al. “Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies.” Fitoterapia, 2011. PMID 21056640; DOI 10.1016/j.fitote.2010.11.014.
  4. Toth PP, et al. “Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia.” Frontiers in Pharmacology, 2016. PMID 26779019; DOI 10.3389/fphar.2015.00299.